PeterMD vs Zealthy

Recorded prices, access and terms.

Decision table

The entries below are recorded provider statements unless a regulatory source is linked. A provider webpage does not independently verify its licenses or quality. PeterMD source · Zealthy source.

ComparePeterMDZealthy
Recorded monthly-plan priceNot recordedNot recorded
Recorded medication/program subtotalSeller's headline: Semaglutide + B12 $149/mo ($447 total) or $139/mo ($834 total). It may require prepayment, a specific dose or introductory terms. The full required cost is not established.Seller's headline: Semaglutide as low as $151/mo, plan term not stated. It may require prepayment, a specific dose or introductory terms. The full required cost is not established.
Full required monthly costNot established: consultation, labs, membership, dose changes and shipping must be checkedNot established: consultation, labs, membership, dose changes and shipping must be checked
Drug type listedCompoundedBrand-name and compounded
ConsultationFree in the record; current conditions unconfirmed$135/mo membership in the record; current conditions unconfirmed
Pharmacy licenseNot independently verified. Obtain the dispensing pharmacy name and verify its state license.Not independently verified. Obtain the dispensing pharmacy name and verify its state license.
Reported states46; confirm eligibility and clinician licensing in your state50; confirm eligibility and clinician licensing in your state
CancellationCancellation reported; notice, minimum term and refund conditions unconfirmedCancellation reported; notice, minimum term and refund conditions unconfirmed
Clinician/support as reportedLicensed physicians, virtual screeningLicensed physicians, ongoing clinical support
Recorded provider check2026-11-062026-11-06

Which should you choose?

Ask each provider for the full cost at your prescribed dose, required labs and visits, the dispensing pharmacy, the clinician's state license, renewal charges and written refund terms. Compare those answers with your clinician.

Compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness or quality before marketing. FDA source and recommendations.

PeterMD: evidence and terms

Read PeterMD's sourced record · PeterMD source

Zealthy: evidence and terms

Recorded FDA letter (2025-09-09): FDA found claims on getzealthy.com for compounded GLP-1 products false or misleading, making the products misbranded under FD&C Act sections 502(a) and 502(bb). FDA letter.

Read Zealthy's sourced record · Zealthy source

Compare the full provider directory · Compare recorded price subtotals

Embody (paid link)

from $49/mo, 12-month plan

Visit Embody